NORTH AMERICAN BUSINESS
  • HOME
  • SUSTAINABILITY
  • INVEST
  • MARKET
  • PARTNERSHIP
  • INNOVATION
  • PEOPLE
  • INSIGHTS
No Result
View All Result
NORTH AMERICAN BUSINESS
  • HOME
  • SUSTAINABILITY
  • INVEST
  • MARKET
  • PARTNERSHIP
  • INNOVATION
  • PEOPLE
  • INSIGHTS
No Result
View All Result
NORTH AMERICAN BUSINESS
No Result
View All Result
Home ALL Chemical

Celanese Expands Capabilities to Support the Sustained-Release Drug Delivery Market

by Ed Johnson
October 11, 2022
A A

Availability of pharmaceutical-grade materials with broad API compatibility key to advancing drug delivery solutions

DALLAS & EDMONTON, Alberta — Celanese Corporation (NYSE: CE), a global chemical and specialty materials company, today announced an investment in expanded capabilities to meet high global demand for pharmaceutical-grade polymers used in the development of implants and inserts for sustained-release drug delivery. The new 1,000-square-foot cleanroom facility, located in Edmonton, Alberta, will focus on cryogenic micronization of VitalDose® EVA material into a powder form that is ready to be blended with small molecules and biologics.

“Our VitalDose® technology is already used in sustained-release drug delivery applications for effective, patient-centric drug delivery for certain ophthalmic diseases, addictive disorders and contraception,” said Susan Rahe, senior director, Celanese pharmaceutical solutions. “Availability of pharmaceutical-grade polymers with broad molecule compatibility is vital to development of innovative drug delivery solutions that provide an improved patient experience. We see an opportunity to improve the future treatment of cancer, retinal disorders and certain disorders of the central nervous system, with the potential to meaningfully improve the lives of people around the world.”

Today’s news builds on the 2021 opening of the Celanese Pharmaceutical Development & Feasibility Lab. The micronizer and clean room facility are being prepared to supply VitalDose® EVA in powder form by early 2023.

“We understand that providing cryogenic grinding reduces complexity for our global customers, allowing them to focus on accelerating the time to market for their solutions,” added Dirk Hair, director, technical and quality assurance at the Celanese Edmonton facility. “Pharmaceutical companies will have the benefit of integrated material production and cryogrinding from our manufacturing facility with the same high-quality standards they’ve come to expect from Celanese.”

Celanese offers cutting-edge medical and pharmaceutical material solutions and expert development support to Pharmaceutical and Medical Device companies worldwide. With more than 40 years of experience supporting key applications and the demanding requirements of the medical market, Celanese is expanding design possibilities as its customers find new ways to deliver a sustained dose of medication over time.

Tags: < Market
ShareTweetShareSend

Related Industries

Chemical

Dow expands portfolio of silicone-based products for photovoltaic assembly

March 7, 2023
Chemical

Celanese and Mitsui & Co., Ltd. to Form Food Ingredients Joint Venture; Extend Existing Fairway Methanol LLC Joint Venture

February 24, 2023
Chemical

Celanese Completes EVA Capacity Expansion at Acetyl Chain Facility in Edmonton

February 21, 2023
Chemical

Dow Recognized among Top 100 Global Innovators™ for 12th consecutive year

February 17, 2023
Chemical

3M recognized as Top 100 Global Innovator 2023

February 17, 2023
Chemical

3M to partner with U.S. federal government on national strategy to curb traffic-related deaths, offering 80 years of science in traffic safety

February 16, 2023

Marriott International Joins the Internet Watch Foundation; Deploys Cisco Technology to Combat Online Child Sexual Abuse Material

February 23, 2023

...

Medtronic named one of World’s Most Ethical Companies

March 14, 2023

...

Volkswagen Group steps up activities in North America – Canada chosen as location for first overseas gigafactory of its battery company PowerCo SE

March 14, 2023

...

voco hotels celebrates 100 properties signed and opened globally

March 8, 2023

...

Sonia Coleman Named Chief Human Resources Officer Of The Walt Disney Company

March 14, 2023

...

Aramco completes $2.65bn acquisition of Valvoline Inc’s global products business (‘Valvoline Global Operations’)

March 3, 2023

...

Honeywell Survey Reveals Increased Expectations For Healthier Workplaces

February 23, 2023

...

chevron and JERA sign MOU to explore carbon capture and storage projects in United States and Australia

March 8, 2023

...

Best Buy recognized as one of the 2023 World’s Most Ethical Companies®

March 14, 2023

...

NORTH AMERICAN BUSINESS (www.na-biz.com) is a leading source of business and corporate news, information, industry trends, market updates and insights across a broad spectrum of industries in North America and worldwide.

INDUSTRIES

  • Aero
  • Agriculture
  • ALL
  • Automotive
  • Business Service
  • Chemical
  • Construction
  • Construction Materials
  • Consumer
  • Education
  • Energy
  • Entertainment
  • Environmental
  • F&B
  • Financial
  • Healthcare
  • Hospitality
  • Industrial
  • IT
  • IT Hardware
  • Logistic
  • Metal & Mining
  • Packaging & Paper
  • Rail
  • Real Estate
  • Telecom

CONTACT US

EDITORIAL:     editor#na-biz.com

PARTNERSHIP:     biz#na-biz.com

HUMAN RESOURCE:     hr#na-biz.com

* (replace # with @)

  • Official Site

Copyright © NA-BIZ.COM All rights reserved.

No Result
View All Result
  • HOME
  • SUSTAINABILITY
  • INVEST
  • MARKET
  • PARTNERSHIP
  • INNOVATION
  • PEOPLE
  • INSIGHTS

Copyright © NA-BIZ.COM All rights reserved.